Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,440.62 +59.27 (+0.71%) Bitcoin USD
62,956.11 +2,039.87 (+3.35%) CMC Crypto 200
1,301.12 -56.88 (-4.19%)
Beam Therapeutics Inc. (BEAM)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 09:47AM EDT. Market open.
| Previous close | 22.54 |
| Open | 22.78 |
| Bid | 22.24 x 400 |
| Ask | 22.62 x 400 |
| Day's range | 22.38 - 22.89 |
| 52-week range | 16.95 - 49.50 |
| Volume | |
| Avg. volume | 1,533,695 |
| Market cap | 1.852B |
| Beta (5Y monthly) | 1.88 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.60 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 48.67 |
Simply Wall St.Beam Therapeutics Inc. (NASDAQ:BEAM) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Beam Therapeutics Inc. ( NASDAQ:BEAM ) shareholders are probably feeling a little disappointed, since its shares fell...
ZacksBeam Therapeutics (BEAM) Q1 Loss Narrows, Revenues Miss
Beam Therapeutics (BEAM) reports mixed first-quarter results. The company remains focused on pipeline development.
GlobeNewswireBeam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference
CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer of Beam, plans to participate in a fireside chat during the RBC Capital Markets 2024 Global Healthcare Conference on Wednesday, May 15, 2024, at 1:35 p.m. ET in New York City. A live webcast will be available in the investor section of the company's website at www.bea
© 2024 Yahoo. All rights reserved.